secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001213900-25-052718
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharmaceuticals increases authorized shares 10x, redeems Series A Preferred for $100
--------------------------------------------------------------------------------

- Authorized shares increased from 26M to 260M; common shares from 16M to 250M.
- Amendment approved at special meeting on June 9, 2025: 547M for, 457M against, 520K abstain.
- Series A Preferred (1B votes) automatically redeemed for $100, mirrored votes cast proportionally.
- Adjournment proposal became moot after amendment approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025052718/0001213900-25-052718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025052718/ea0245189-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-052718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer